V Gaelle ROULLIN

Prof. V Gaelle ROULLIN

University of Montreal, Montreal, Canada
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
CECloé L. Esposito
Cloé L. Esposito
Plamen KirilovPlamen Kirilov
Plamen Kirilov
VRV Gaelle ROULLIN
V Gaelle ROULLIN

8 March 2002 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
VRV Gaelle ROULLIN
V Gaelle ROULLIN
JDJean-Robert Deverre
Jean-Robert Deverre
LLLaurent Lemaire
Laurent Lemaire
FHFrançois Hindré
François Hindré
MVMarie-Claire Venier-Julienne
Marie-Claire Venier-Julienne
JBJean-Pierre Benoit
Jean-Pierre Benoit

14 July 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
STSoudeh F. Tehrani
Soudeh F. Tehrani
PBPriyanshu Bharadwaj
Priyanshu Bharadwaj
JCJeanne Leblond Chain
Jeanne Leblond Chain
VRV Gaelle ROULLIN
V Gaelle ROULLIN

18 December 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FBFlorian Bernard-Patrzynski
Florian Bernard-Patrzynski
MLMarc-André Lécuyer
Marc-André Lécuyer
IPIna Puscas
Ina Puscas
IBImane Boukhatem
Imane Boukhatem
MCMarc Charabati
Marc Charabati
VRV Gaelle ROULLIN
V Gaelle ROULLIN
Primary cell isolation from the central nervous system (CNS) has allowed fundamental understanding of blood-brain barrier (BBB) properties. However, poorly described isolation techniques or suboptimal cellular purity has been a weak point of some published scientific articles. Here, we describe in detail how to isolate and enrich, using a common approach, endothelial cells (ECs) from adult mouse brains, as well as pericytes (PCs) and astrocytes (ACs) from newborn mouse brains. Our approach allowed the isolation of these three brain cell types with purities of around 90%. Furthermore, using our protocols, around 3 times more PCs and 2 times more ACs could be grown in culture, as compared to previously published protocols. The cells were identified and characterized using flow cytometry and confocal microscopy. The ability of ECs to form a tight monolayer was assessed for passages 0 to 3. The expression of claudin-5, occludin, zonula occludens-1, P-glycoprotein-1 and breast cancer resistance protein by ECs, as well as the ability of the cells to respond to cytokine stimuli (TNF-α, IFN-γ) was also investigated by q-PCR. The transcellular permeability of ECs was evaluated in the presence of pericytes or astrocytes in a Transwell® model by measuring the transendothelial electrical resistance (TEER), dextran-FITC and sodium fluorescein permeability. Overall, ECs at passages 0 and 1 featured the best properties valued in a BBB model. Furthermore, pericytes did not increase tightness of EC monolayers, whereas astrocytes did regardless of their seeding location. Finally, ECs resuspended in fetal bovine serum (FBS) and dimethyl sulfoxide (DMSO) could be cryopreserved in liquid nitrogen without affecting their phenotype nor their capacity to form a tight monolayer, thus allowing these primary cells to be used for various longitudinal in vitro studies of the blood-brain barrier.

23 December 2015 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
GPGhislain Djiokeng Paka
Ghislain Djiokeng Paka
SDSihem Doggui
Sihem Doggui
AZAhlem Zaghmi
Ahlem Zaghmi
RSRamia Safar
Ramia Safar
LDLé Dao
Lé Dao
CRCharles Ramassamy
Charles Ramassamy

6 January 2023 in Drug Discovery Today
Verified
Journal Article
Closed access
SMSeng Manivong
Seng Manivong
ACAurélie Cullier
Aurélie Cullier
FAFabrice Audigié
Fabrice Audigié
XBXavier Banquy
Xavier Banquy
FMFlorina Moldovan
Florina Moldovan
VRV Gaelle ROULLIN
V Gaelle ROULLIN